GENE SILENCER Trademark

Trademark Overview


On Wednesday, August 23, 2000, a trademark application was filed for GENE SILENCER with the United States Patent and Trademark Office. The USPTO has given the GENE SILENCER trademark a serial number of 76122110. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, September 18, 2002. This trademark is owned by EPIGENESIS Pharmaceuticals, Inc.. The GENE SILENCER trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Describing and providing medical diagnostic and therapeutic preparations, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small organic and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vascoconstriction, inflammation, allergies, impede...
gene silencer

General Information


Serial Number76122110
Word MarkGENE SILENCER
Filing DateWednesday, August 23, 2000
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, September 18, 2002
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDescribing and providing medical diagnostic and therapeutic preparations, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small organic and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vascoconstriction, inflammation, allergies, impeded respiration, Acute Respiratory Disease Syndrom (ARDS), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating Supra Ventricular Tachycardia (SVT), adenosine stress test, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vascoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc., as well as metastatic cancers, e.g., cancers which metastasized to the lung(s), breast, liver and prostate
Pseudo MarkGENE SILENCER

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 21, 2000
Primary Code042
First Use Anywhere DateFriday, May 31, 1996
First Use In Commerce DateFriday, May 31, 1996

Trademark Owner History


Party NameEPIGENESIS Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Trademark Events


Event DateEvent Description
Wednesday, September 18, 2002ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, February 6, 2002NON-FINAL ACTION MAILED
Thursday, September 27, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 22, 2001NON-FINAL ACTION MAILED
Thursday, March 8, 2001ASSIGNED TO EXAMINER
Tuesday, February 13, 2001ASSIGNED TO EXAMINER